Clinical Trial Update: NT-3 Levels and Function in Individuals With CMT

View source ↗

Summary

A clinical trial update examining NT-3 levels and function in individuals with Charcot-Marie-Tooth disease; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Charcot-marie-tooth Disease
• Inflammatory Demyelinating Polyneuropathy
• Peripheral Neuropathy

Snippet

Sponsor: Zarife Sahenk | Conditions: Charcot-Marie-Tooth Disease, Peripheral Neuropathy | Status: NOT_YET_RECRUITING